미국의 의료용 콜드체인 포장 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 포장 형태별, 온도 요건별, 용도별, 부문별 예측(2026-2033년)

Market Size & Trends:

The U.S. healthcare cold chain packaging market size was estimated at USD 3.72 billion in 2025 and is projected to reach USD 9.32 billion by 2033, growing at a CAGR of 12.2% from 2026 to 2033. This is attributed to the increasing development and distribution of temperature-sensitive drugs, especially biologics, vaccines, cell and gene therapies, and advanced specialty medicines.

These products often require precise thermal conditions throughout storage and transportation to retain potency and efficacy. For example, mRNA-based vaccines and many monoclonal antibodies lose effectiveness if exposed to even minor temperature variations, necessitating high-performance insulated packaging and ultracold solutions.

As pharmaceutical companies continue to shift focus from traditional small-molecule drugs toward biologics and personalized medicines, the reliance on robust cold chain packaging has surged. The demand for cold chain packaging in the U.S. healthcare market is expanding steadily, driven by structural shifts in pharmaceutical innovation, healthcare delivery models, regulatory oversight, and supply-chain risk management. Unlike earlier periods when cold chain requirements were limited to a narrow set of vaccines and biologics, temperature control has now become a foundational requirement across a broad and growing segment of healthcare products.

A primary factor driving the growth is the rapid increase in temperature-sensitive pharmaceuticals, particularly biologics, specialty drugs, vaccines, and advanced therapies such as cell and gene treatments. These products are inherently unstable outside narrow temperature ranges and can lose potency or become unusable if exposed to even brief temperature excursions. The U.S. pharmaceutical pipeline is increasingly dominated by biologics rather than traditional small-molecule drugs, which significantly raises the volume of products requiring refrigerated, frozen, or ultra-cold conditions. As a result, pharmaceutical manufacturers are investing heavily in validated cold chain packaging solutions that can ensure thermal stability across long and complex distribution routes.

Closely linked to this trend is the strong growth in biopharmaceutical research, clinical trials, and commercialization activity within the U.S. The country hosts a large share of global clinical trials, many of which involve investigational drugs that must be transported between manufacturing sites, trial centers, laboratories, and storage facilities under strict temperature controls. These shipments often span long distances and multiple handovers, increasing the risk of temperature deviation. Consequently, demand is rising for high-performance insulated packaging, phase-change materials, and qualified shipping systems that can maintain temperature integrity throughout the trial lifecycle.

U.S. Healthcare Cold Chain Packaging Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare cold chain packaging market report based on product, temperature requirement, packaging format, and application:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Insulated Pallet Shippers
• Insulated Containers
• Vacuum Insulated Panels
• Cold Packs & Refrigerants
• Labels & Sensors
• Others
• Temperature Requirement Outlook (Revenue, USD Million, 2021 - 2033)
• Controlled Room Temperature (CRT)
• Refrigerated (2°C-8°C)
• Frozen (-20°C to -40°C)
• Cryogenic (<-80°C)
• Packaging Format Outlook (Revenue, USD Million, 2021 - 2033)
• Active
• Passive
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Companies
• Clinical Research Organizations
• Hospitals and Healthcare Providers
• Research Institutes & Labs
• Logistics and Distribution Companies
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Research Methodology
  • 1.1.1. Market Segmentation
  • 1.1.2. Market Definition
• 1.2. Research Scope & Assumptions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing
• 1.7. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot, (USD Million)
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Healthcare Cold Chain Packaging Market Variables, Trends, and Scope

• 3.1. Market Lineage Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Technology Overview
• 3.4. Supply Demand Gap Analysis, 2025
• 3.5. Sustainability Trends
• 3.6. Regulatory Framework
• 3.7. Market Dynamics
  • 3.7.1. Market Driver Analysis
  • 3.7.2. Market Restraint Analysis
  • 3.7.3. Market Challenge Analysis
• 3.8. Business Environment Analysis
  • 3.8.1. Porter's Five Forces Analysis
  • 3.8.2. PESTEL Analysis

Chapter 4. U.S. Healthcare Cold Chain Packaging Market: Product Estimates & Trend Analysis

• 4.1. Key Takeaways
• 4.2. Product Movement Analysis & Market Share, 2025 & 2033
  • 4.2.1. Insulated Pallet Shippers
    • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.2. Insulated Containers
    • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.3. Vacuum Insulated Panels
    • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.4. Cold Packs & Refrigerants
    • 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.5. Labels & Sensors
    • 4.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.6. Others
    • 4.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Healthcare Cold Chain Packaging Market: Packaging Format Estimates & Trend Analysis

• 5.1. Key Takeaways
• 5.2. Packaging Format Movement Analysis & Market Share, 2025 & 2033
  • 5.2.1. Active
    • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.2.2. Passive
    • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Healthcare Cold Chain Packaging Market: Temperature Requirement Format Estimates & Trend Analysis

• 6.1. Key Takeaways
• 6.2. Temperature Requirement Movement Analysis & Market Share, 2025 & 2033
  • 6.2.1. Controlled Room Temperature (CRT)
    • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.2. Refrigerated (2°C-8°C)
    • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.3. Frozen (-20°C to -40°C)
    • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.4. Cryogenic (<-80°C)
    • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Healthcare Cold Chain Packaging Market: Application Format Estimates & Trend Analysis

• 7.1. Key Takeaways
• 7.2. Application Movement Analysis & Market Share, 2025 & 2033
  • 7.2.1. Biopharmaceutical Companies
    • 7.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.2. Clinical Research Organizations
    • 7.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.3. Hospitals and Healthcare Providers
    • 7.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.4. Research Institutes & Labs
    • 7.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.5. Logistics and Distribution Companies
    • 7.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.6. Others
    • 7.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Key Players & Recent Developments & Their Impact on the Industry
• 8.2. Vendor Landscape
  • 8.2.1. Company Categorization
  • 8.2.2. List of Potential Raw Material Suppliers & Channel Partners
• 8.3. Competitive Dynamics
  • 8.3.1. Market Share Analysis
  • 8.3.2. Company Market Position Analysis
  • 8.3.3. Strategy Mapping
    • 8.3.3.1. Expansions
    • 8.3.3.2. Mergers & Acquisitions
    • 8.3.3.3. Collaborations
    • 8.3.3.4. New Product Launches
    • 8.3.3.5. Others

Chapter 9. Company Listing (Overview, Financial Performance, Product Overview)

• 9.1. Sealed Air Corporation
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
• 9.2. Peli BioThermal LLC
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
• 9.3. CSafe
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
• 9.4. DGP Intelsius LLC
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
• 9.5. ThermoSafe Technologies Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
• 9.6. Cryoport Systems, LLC
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking